SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · Real-Time Price · USD
5.14-0.20 (-3.78%)
 
Market Cap663.57M+29.9%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out129.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume174,115.724
Open5.26
Previous Close5.34
Day's Range5.04 - 5.28
52-Week Range3.31 - 6.21
Betan/a
AnalystsBuy
Price Target4.88(-5.03%)
Earnings Daten/a
-3.75% (1D)
No price history available.
Insider Score
––Not scored
CTKB Insider Score

Insiders here have filed 25 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About CTKB

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Address
47215 Lakeview Blvd, Fremont, CA, 94538-6407, United States
Market Cap
664 million
Employees
682
Industrial Classification
Medical Devices
1 Day
-5.15%
5 Days
-12.82%
1 Month
+7.08%
6 Months
+9.63%
1 Year
+29.87%

$CTKB stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CTKB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CTKB's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CTKB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CTKB Revenue by Segment or Geography

$67.26MTotal
SegmentRevenue% of All
Direct sales channel$33.20M49.36%
Academia and government$19.12M28.43%
Distributor channel$14.94M22.21%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CTKB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CTKB from public contracts

Source: USAspending.gov

CTKB Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for CTKB yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from CTKB’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.